- Home
- SBS vs HOLX Comparison
SBS vs HOLX Comparison
Compare SBS & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBS
- HOLX
- Stock Information
- Founded
- SBS 1954
- HOLX 1985
- Country
- SBS Brazil
- HOLX United States
- Employees
- SBS N/A
- HOLX N/A
- Industry
- SBS Water Supply
- HOLX Medical Electronics
- Sector
- SBS Utilities
- HOLX Health Care
- Exchange
- SBS Nasdaq
- HOLX Nasdaq
- Market Cap
- SBS 14.4B
- HOLX 16.5B
- IPO Year
- SBS 2002
- HOLX 1990
- Fundamental
- Price
- SBS $26.56
- HOLX $74.32
- Analyst Decision
- SBS
- HOLX Hold
- Analyst Count
- SBS 0
- HOLX 15
- Target Price
- SBS N/A
- HOLX $79.64
- AVG Volume (30 Days)
- SBS 1.0M
- HOLX 5.0M
- Earning Date
- SBS 11-10-2025
- HOLX 11-03-2025
- Dividend Yield
- SBS 2.06%
- HOLX N/A
- EPS Growth
- SBS N/A
- HOLX N/A
- EPS
- SBS 1.98
- HOLX 2.49
- Revenue
- SBS $6,502,517,346.00
- HOLX $4,100,500,000.00
- Revenue This Year
- SBS N/A
- HOLX $6.23
- Revenue Next Year
- SBS $11.93
- HOLX $5.37
- P/E Ratio
- SBS $13.49
- HOLX $29.83
- Revenue Growth
- SBS N/A
- HOLX 1.74
- 52 Week Low
- SBS $13.87
- HOLX $51.90
- 52 Week High
- SBS $26.85
- HOLX $80.31
- Technical
- Relative Strength Index (RSI)
- SBS 75.64
- HOLX 68.72
- Support Level
- SBS $25.35
- HOLX $74.07
- Resistance Level
- SBS $25.88
- HOLX $74.66
- Average True Range (ATR)
- SBS 0.45
- HOLX 0.24
- MACD
- SBS 0.17
- HOLX -0.16
- Stochastic Oscillator
- SBS 88.15
- HOLX 57.72
About SBS Companhia de saneamento Basico
Companhia De Saneamento Basico Do Estado De Sao Paulo is engaged in the provision of basic and environmental sanitation services in the Sao Paulo State and supplies treated water and sewage services on a wholesale basis. The company operates in a single segment, which is Sanitation services.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.